+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pain Management Therapeutics Market by Drug Class; by Indication, and by Distribution Channel: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

  • ID: 4853733
  • Report
  • September 2018
  • Region: Global
  • 130 pages
  • Zion Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pain management therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pain management therapeutics market on a global level.

In order to give the users of this report a comprehensive view of the pain management therapeutics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein drug class, indication, and distribution channel segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view of the pain management therapeutics market by segmenting the market based on drug class, indication, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on drug class, the market is segmented into anesthetics, NSAIDS, anticonvulsants, antidepressants, anti-migraine agents, non-narcotic analgesics, opioids (tramadol, oxycodone, hydrocodone, and others). By indication, the market for pain management therapeutics market is segmented as neuropathic pain, arthritic pain, cancer pain, post-operative pain, chronic back pain, fibromyalgia, and migraine. Based on the distribution channel, the market is segmented as hospitals pharmacy, retail pharmacy, and online pharmacy. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of Middle East and Africa. This segmentation includes demand for pain management therapeutics market based on individual drug class, indication, and distribution channel in all the regions and countries.

The report also includes detailed profiles of end players such as Pfizer Inc., Endo International Plc., Depomed, Inc., Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, AstraZeneca plc., Novartis AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline Plc., and Abbott Laboratories, among others 

This report segments the global pain management therapeutics market as follows:

Global Pain Management Therapeutics Market: Drug Class Segment Analysis

  • Anesthetics
  • NSAIDS
  • Anticonvulsants
  • Antidepressants
  • Anti-migraine agents
  • Non-narcotic analgesics
  • Opioids
  • Tramadol
  • Oxycodone
  • Hydrocodone
  • Others

Global Pain Management Therapeutics Market: Indication Segment Analysis

  • Neuropathic Pain
  • Arthritic Pain
  • Cancer pain
  • Post-operative Pain
  • Chronic Back Pain
  • Fibromyalgia
  • A migraine    

Global Pain Management Therapeutics Market: Distribution Channel Segment Analysis

  • Hospitals Pharmacy 
  • Retail Pharmacy
  • Online Pharmacy 

Global Pain Management Therapeutics Market: Regional Segment Analysis

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • The Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Pain Management Therapeutics market, 2017 - 2024(USD Million)
    • 2.2. Global Pain Management Therapeutics market: snapshot
  • Chapter 3. Pain Management Therapeutics Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Pain Management Therapeutics market drivers: impact analysis
      • 3.2.2. Favorable Regulatory Scenario
      • 3.2.3. Rising Geriatric Population
      • 3.2.4. Increasing Incidence of Chronic Diseases
    • 3.3. Market Restraints
      • 3.3.1. Global Pain Management Therapeutics market restraints: impact analysis
      • 3.3.2. Availability of Alternative Therapies
      • 3.3.3. Patent Expiration of Prescription Drugs
    • 3.4. Opportunities
      • 3.4.1. Advancements in Drug Development
      • 3.4.2. Untapped Markets in Developing Economies
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by Drug Class segment
      • 3.6.2. Market attractiveness analysis, by Indication segment
      • 3.6.3. Market attractiveness analysis, by Distribution Channel segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Pain Management Therapeutics Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Pain Management Therapeutics market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Pain Management Therapeutics Market- Drug Class Segment Analysis
    • 5.1. Global Pain Management Therapeutics market: product overview
      • 5.1.1. Global Pain Management Therapeutics market revenue share, by Drug Class, 2017 and 2024
    • 5.2. Anesthetics
      • 5.2.1. Global Pain Management Therapeutics market for Anesthetics, 2017 - 2024(USD Million)
    • 5.3. NSAIDS
      • 5.3.1. Global Pain Management Therapeutics market for NSAIDS, 2017 - 2024 (USD Million)
    • 5.4. Anticonvulsants
      • 5.4.1. Global Pain Management Therapeutics market for Anticonvulsants, 2017 - 2024 (USD Million)
    • 5.5. Antidepressants
      • 5.5.1. Global Pain Management Therapeutics market for Antidepressants, 2017 - 2024 (USD Million)
    • 5.6. Anti-migraine Agents
      • 5.6.1. Global Pain Management Therapeutics market for Anti-migraine Agents, 2017 - 2024 (USD Million)
    • 5.7. Non-narcotic Analgesics
      • 5.7.1. Global Pain Management Therapeutics market for Non-narcotic Analgesics, 2017 - 2024 (USD Million)
    • 5.8. Opioids
      • 5.8.1. Global Pain Management Therapeutics market for Opioids, 2017 - 2024 (USD Million)
        • 5.8.1.1. Tramadol
        • 5.8.1.2. Oxycodone
        • 5.8.1.3. Hydrocodone
        • 5.8.1.4. Others
  • Chapter 6. Global Pain Management Therapeutics Market- Indication Segment Analysis
    • 6.1. Global Pain Management Therapeutics market: Indication overview
      • 6.1.1. Global Pain Management Therapeutics market revenue share, by Indication, 2017 and 2024
    • 6.2. Neuropathic Pain
      • 6.2.1. Global Pain Management Therapeutics market for Neuropathic Pain, 2017 - 2024 (USD Million)
    • 6.3. Arthritic Pain
      • 6.3.1. Global Pain Management Therapeutics market for Arthritic Pain, 2017 - 2024 (USD Million)
    • 6.4. Cancer Pain
      • 6.4.1. Global Pain Management Therapeutics market for Cancer Pain, 2017 - 2024 (USD Million)
    • 6.5. Post-operative Pain
      • 6.5.1. Global Pain Management Therapeutics market for Post-operative Pain, 2017 - 2024 (USD Million)
    • 6.6. Chronic Back Pain
      • 6.6.1. Global Pain Management Therapeutics market for Chronic Back Pain, 2017 - 2024 (USD Million)
    • 6.7. Fibromyalgia
      • 6.7.1. Global Pain Management Therapeutics market for Fibromyalgia, 2017 - 2024 (USD Million)
    • 6.8. Migraine
      • 6.8.1. Global Pain Management Therapeutics market for Migraine, 2017 - 2024 (USD Million)
  • Chapter 7. Global Pain Management Therapeutics Market- Distribution Channel Segment Analysis
    • 7.1. Global Pain Management Therapeutics market: Distribution Channel type overview
      • 7.1.1. Global Pain Management Therapeutics market revenue share, by Distribution Channel, 2017 and 2024
    • 7.2. Hospitals Pharmacy
      • 7.2.1. Global Pain Management Therapeutics market for Hospitals Pharmacy, 2017 - 2024 (USD Million)
    • 7.3. Retail Pharmacy
      • 7.3.1. Global Pain Management Therapeutics market for Retail Pharmacy, 2017 - 2024 (USD Million)
    • 7.4. Online Pharmacy
      • 7.4.1. Global Pain Management Therapeutics market for Online Pharmacy,2017 - 2024(USD Million)
  • Chapter 8. Global Pain Management Therapeutics Market- Regional Segment Analysis
    • 8.1. Global Pain Management Therapeutics market: regional overview
      • 8.1.1. Global Pain Management Therapeutics market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
      • 8.2.2. North America Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
      • 8.2.3. North America Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.2.4.2. U.S. Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.2.4.3. U.S. Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.2.5.2. Rest of North America Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.2.5.3. Rest of North America Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
      • 8.3.2. Europe Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
      • 8.3.3. Europe Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024 (USD Million)
        • 8.3.4.2. U.K. Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.3.4.3. U.K. Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.3.5.2. Germany Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.3.5.3. Germany Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.3.6.2. France Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.3.6.3. France Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.3.7. Italy
        • 8.3.7.1. Italy Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.3.7.2. Italy Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.3.7.3. Italy Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.3.8. Spain
        • 8.3.8.1. Spain Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.3.8.2. Spain Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.3.8.3. Spain Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.3.9.2. Rest of Europe Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.3.9.3. Rest of Europe Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024 (USD Million)
      • 8.4.2. Asia Pacific Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
      • 8.4.3. Asia Pacific Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.4.4.2. China Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.4.4.3. China Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.4.5.2. Japan Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.4.5.3. Japan Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.4.6.2. India Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.4.6.3. India Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.4.7. Southeast Asia
        • 8.4.7.1. Southeast Asia Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.4.7.2. Southeast Asia Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.4.7.3. Southeast Asia Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.4.8.2. Rest of Asia Pacific Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.4.8.3. Rest of Asia Pacific Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.5. Latin America
        • 8.5.1. Latin America Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.5.2. Latin America Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.5.3. Latin America Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.5.4.2. Brazil Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.5.4.3. Brazil Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.5.5.2. Rest of Latin America Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.5.5.3. Rest of Latin America Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
      • 8.6.2. Middle East & Africa Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
      • 8.6.3. Middle East and Africa Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.6.4. GCC Countries
        • 8.6.4.1. GCC Countries Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.6.4.2. GCC Countries Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.6.4.3. GCC Countries Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
      • 8.6.5. Rest of Middle East and Africa
        • 8.6.5.1. Rest of Middle East and Africa Pain Management Therapeutics market revenue, by Drug Class, 2017 - 2024(USD Million)
        • 8.6.5.2. Rest of Middle East & Africa Pain Management Therapeutics market revenue, by Indication, 2017 - 2024(USD Million)
        • 8.6.5.3. Rest of Middle East and Africa Pain Management Therapeutics market revenue, by Distribution Channel, 2017 - 2024(USD Million)
  • Chapter 9. Company Profile
    • 9.1. Pfizer Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Endo International plc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Depomed, Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Purdue Pharma L.P.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Teva Pharmaceutical Industries Ltd.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Mallinckrodt Pharmaceuticals
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. AstraZeneca plc.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Novartis AG
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Merck & Co., Inc.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Johnson & Johnson Services, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. GlaxoSmithKline plc.
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments
    • 9.12. Abbott Laboratories
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Product portfolio
      • 9.12.4. Business strategy
      • 9.12.5. Recent developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll